SCHEMBL25547642

SCHEMBL25547642

CNN1CCC(OP(=O)(O)O)CC1

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
INPP5A Q14642 2/20 0.40
SMPD1 P17405 1/20 0.31
ITPR3 Q14573 3/20 0.30
ITPR2 Q14571 1/20 0.30
ITPR1 Q14643 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL685174 0.78 INPP5A (0.44) INPP5ASMPD1
SCHEMBL2238965 0.73
SCHEMBL10241703 0.73 SMN1; SMN2 (0.44) INPP5A
SCHEMBL681678 0.73 HRH3 (0.41) INPP5A
SCHEMBL13602505 0.73 INPP5A (0.40) INPP5A
SCHEMBL24407723 0.73 INPP5A (0.40) INPP5ASMPD1ITPR3ITPR2ITPR1
SCHEMBL31470602 0.71 INPP5A (0.41) INPP5A
SCHEMBL22479228 0.71 INPP5A (0.41) INPP5A
SCHEMBL2149479 0.69 INPP5A (0.52) INPP5ASMPD1ITPR3ITPR2ITPR1
SCHEMBL2238021 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3787626-B1 PHOSPHONAMIDATES THAT ARE BCL FAMILY ANTAGONISTS FOR USE IN CLINICAL MANAGEMENT OF CONDITIONS CAUSED OR MEDIATED BY SENESCENT CELLS AND FOR TREATING CANCER UNITY BIOTECHNOLOGY INC (US) 2023-06-07 EP disclosed